Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Holding HRTS?
Track your performance easily
HRTS Price & Analysis
HRTS ETF Chart & Stats
Day’s Range― - ―
52-Week Range$28.81 - $36.03
Previous Close$29.15
VolumeN/A
Average Volume (3M)15.79K
AUM71.27M
NAV29.11
Expense Ratio0.75%
Holdings Count45
Beta1.15
Inception DateNov 21, 2023
Last Dividend Ex-Date
Dec 11, 2024Dividend Yield
(1.61%)Shares Outstanding2,480,000
Standard Deviation0.06
10 Day Avg. Volume4,184,019
30 Day Avg. Volume15,788
Alpha-0.02
Tema Cardiovascular and Metabolic ETF (HRTS) Fund Flow Chart
Tema Cardiovascular and Metabolic ETF (HRTS) 1 year Net Flows: $61M
HRTS ETF News
HRTS ETF FAQ
What was HRTS’s price range in the past 12 months?
HRTS lowest ETF price was $28.81 and its highest was $36.03 in the past 12 months.
What is the AUM of HRTS?
As of Dec 19, 2024 The AUM of HRTS is 71.27M.
Is HRTS overvalued?
According to Wall Street analysts HRTS’s price is currently Undervalued.
Does HRTS pay dividends?
HRTS pays a Notavailable dividend of $0.469 which represents an annual dividend yield of 1.61%. See more information on HRTS dividends here
How many shares outstanding does HRTS have?
HRTS has 2,480,000 shares outstanding.
Which hedge fund is a major shareholder of HRTS?
Currently, no hedge funds are holding shares in HRTS
HRTS ETF Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
For ETFs, the calculations for the Smart Score, Analyst Consensus, Price Target, Blogger Sentiment, News Sentiment and Insider Transactions are based on the weighted average of the ETF's holdings and some additional factors. Hedge Fund Trend, Crowd Wisdom and Technicals are based on the actual ETF ticker.
Top 10 Holdings
Eli Lilly And Company
7.24%
Vertex Pharmaceuticals Inc.
5.14%
Alnylam Pharmaceuticals
5.09%
Bridgebio Pharma
4.21%
Novo Nordisk A/S (UK)
3.99%
Crinetics Pharma
3.93%
Ascendis Pharma A/S
3.90%
Chugai Pharmaceutical Co
3.82%
AstraZeneca plc
3.65%
Amgen Inc
3.30%
Total44.29%
ETF Description
Tema Cardiovascular and Metabolic ETF
HRTS is an actively managed fund that concentrates on companies focused on the treatment of cardiovascular diseases and/or metabolic diseases from companies all around the world. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive.